Home > Insider Trading > Filing (0001209191-23-018046)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1630627	Treace Medical Concepts Inc.	TMCI	Surgical & Medical Instruments & Apparatus (3841)	471052611

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1856380	T. John Treace	C/O Treace Medical Concepts, Inc. 100 Palmetto Park Place Ponte Vedra FL 32081	Chief Executive Offer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-09	2,075	$24.41	5,539,380	No	4	S	Direct
Common Stock	Acquisiton	2023-03-10	82,475	$0.00	5,621,855	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Stock Option (Right To Buy)	Stock Option (Right to Buy)	Acquisiton	2023-03-10	186,900	$0.00	186,900	$24.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
186,900		2033-03-10	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,605,000	Indirect	By Spouse
Common Stock	1,471,250	Indirect	By Spouse as cotrustee of a trust dated Sept 30, 2020
Common Stock	1,839,063	Indirect	As Trustee of a trust dated Sept 25, 2020
Common Stock	408,816	Indirect	As Co-Trustee of a trust dated July 29, 2021

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with thevesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does notrepresent a discretionary transaction by the Reporting Person.
Includes 25,406 restricted stock units.
Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for eachRSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
Includes 107,881 RSUs.
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.
The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027;subject to Reporting Person's providing continued service to Issuer through each vesting date.